Dr. Sulaiman Al Habib Medical Services Group Company Website

Dr. Sulaiman Al Habib Medical Services Group Company

SASE-4013

Basic

  • Market Cap

    SAR 98.49B

  • EV

    SAR 102.11B

  • Shares Out

    350M

  • Revenue

    SAR 9,722.97M

  • Employees

    —

Margins

  • Gross

    34.43%

  • EBITDA

    24.76%

  • Operating

    22.02%

  • Pre-Tax

    22.9%

  • Net

    21.68%

  • FCF

    -7.79%

Returns (5Yr Avg)

  • ROA

    12.83%

  • ROTA

    25.06%

  • ROE

    25.06%

  • ROCE

    16.4%

  • ROIC

    17.84%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    SAR 295.75

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    SAR 2,529.27M

  • Net Debt

    SAR 3,321.86M

  • Debt/Equity

    0.84

  • EBIT/Interest

    31.49

Growth (CAGR)

  • Rev 3Yr

    16.1%

  • Rev 5Yr

    15.92%

  • Rev 10Yr

    —

  • Dil EPS 3Yr

    23.17%

  • Dil EPS 5Yr

    20.81%

  • Dil EPS 10Yr

    —

  • Rev Fwd 2Yr

    22.85%

  • EBITDA Fwd 2Yr

    21.87%

  • EPS Fwd 2Yr

    14.37%

  • EPS LT Growth Est

    17.97%

Dividends

  • Yield

    —

  • Payout

    55.13%

  • DPS

    SAR 3.32

  • DPS Growth 3Yr

    13.02%

  • DPS Growth 5Yr

    —

  • DPS Growth 10Yr

    —

  • DPS Growth Fwd 2Yr

    19.76%

Select a metric from the list below to chart it

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Metric
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM

Total Revenues

5,016.3

5,861.6

7,250.5

8,310.7

9,508.4

9,723

Total Revenues % Chg.

—

9.3%

16.9%

23.7%

14.6%

14.4%

12.7%

Cost of Goods Sold, Total

3,501.6

4,008.8

4,934

5,578.1

6,254.6

6,375.5

Gross Profit

1,514.7

1,852.8

2,316.4

2,732.7

3,253.8

3,347.5

Selling General & Admin Expenses, Total

647

737.9

850.3

1,032.2

1,158.2

1,206.4

Other Operating Expenses, Total

647

737.9

850.3

1,032.2

1,158.2

1,206.4

Operating Income

867.7

1,114.9

1,466.2

1,700.5

2,095.6

2,141.2

Interest Expense, Total

-28

-48.5

-37.9

-49.4

-70.1

-68

Interest And Investment Income

—

—

—

20.5

13.1

9.9

40.7

82.1

82.1

Net Interest Expenses

-7.5

-35.4

-28

-8.6

12

14.1

Income (Loss) On Equity Invest.

1.5

1.8

7.5

19.6

22.2

22.5

Other Non Operating Income (Expenses)

41.5

46.6

55.7

85.2

40.1

49

EBT, Excl. Unusual Items

903.3

1,127.8

1,501.3

1,796.7

2,170

2,226.8

Gain (Loss) On Sale Of Assets

—

—

—

—

—

—

EBT, Incl. Unusual Items

903.3

1,127.8

1,501.3

1,796.7

2,170

2,226.8

Income Tax Expense

65.7

92.8

114.1

107.7

68.5

53.4

Earnings From Continuing Operations

837.6

1,035

1,387.3

1,688.9

2,101.5

2,173.4

Minority Interest

32.6

20.5

-10.7

-38.2

-55.5

-65.7

Net Income

870.2

1,055.5

1,376.6

1,650.8

2,046

2,107.7

Net Income to Common Incl Extra Items

870.2

1,055.5

1,376.6

1,650.8

2,046

2,107.7

Net Income to Common Excl. Extra Items

870.2

1,055.5

1,376.6

1,650.8

2,046

2,107.7

Total Shares Outstanding

350

350

350

350

350

350

Weighted Avg. Shares Outstanding

350

350

350

350

350

350

Weighted Avg. Shares Outstanding Dil

350

350

350

350

350

350

EPS

2.5

3

3.9

4.7

5.8

6

EPS Diluted

2.5

3

3.9

4.7

5.8

6

EBITDA

1,073.8

1,378.1

1,728.3

1,960.3

2,358.2

2,407.7

Effective Tax Rate

7.3%

8.2%

7.6%

6%

3.2%

2.4%